Laviana Raises $14 Million for CDMO Operations in China

Laviana B+ financing CDMO
Published on: September 10, 2019

Laviana Pharma of China raised about $14 million in a B+ financing to develop its CDMO operations. Founded in 2005, Laviana offers outsourced process and manufacturing services for pharma companies, especially chemistry-related services. The company has three facilities in China — Beijing, Tianjin and Taizhou — plus a business office in the US. The company announced a similar $15 million funding in January 2081. The latest funding was led by V-Capital of Shanghai and included Guangdong’s CMW Asset Management.

Biotechnology China China News Healthcare Services Life Science Pharmaceutical